在前列腺癌中,MLC1过度表达通过PI3K/AKT信号通路抑制瘤进展
Zonglin Wu1,2, Jinliang Ni3,4, Houliang Zhang3
1Department of Urology, Putuo People's Hospital, School of Medicine, Tongji University, Shanghai, 200060, China.
Advanced biology
|October 11, 2023
概括
通过抑制PI3K/AKT通路,MLC1在前列腺癌 (PC) 中表现出抗瘤作用. 较低的MLC1水平与较差的PC结果相关,表明其治疗潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 前列腺癌 (PC) 是一种具有高死亡率的男性恶性瘤.
- MLC1与瘤进展有关,但其在PC中的具体作用尚不清楚.
研究的目的:
- 为了验证MLC1在前列腺癌中的抗瘤作用.
- 阐明MLC1在PC中的作用的基础分子机制.
主要方法:
- 使用TCGA和GTEx数据库对PC中MLC1表达的分析.
- 在体外实验中评估MLC1调制后的扩散,入侵和迁移.
- 评估瘤生长抑制的体内研究.
- 对PI3K/AKT信号通路的研究.
主要成果:
- 与正常组织相比,PC组织中的MLC1表达显著下降.
- 降低MLC1与转移的增加和患者存活率的降低相关.
- 抑制MLC1通过PI3K/AKT通路的失活来抑制PC细胞的增殖,入侵和迁移.
- 降低MLC1的调节促进了PC的进展,而Gefitinib可以逆转这种进展.
- 在体内,MLC1可以降低瘤体积.
结论:
- 在前列腺癌中,MLC1表现出显著的抗瘤特性.
- MLC1通过抑制PI3K/AKT信号通路而起作用.
- MLC1代表了前列腺癌治疗的潜在治疗标.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K


